MYCAPSSA® (octreotide) Delayed-Release Oral Capsules: A New Option for Appropriate Patients with Acromegaly
Product Theater Presentation
Anthony Heaney, MD, PhD
University of California-Los Angeles, Los Angeles, California, USA
Dr. Heaney is a Professor at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). His primary areas of clinical and research interest involve the pathogenesis of pituitary tumors and exploiting novel molecular targets to develop innovative treatments for pituitary tumors, and other neuroendocrine tumors. Dr. Heaney has published extensively.

Disclosures:

N/A - No CME credits
Not Currently Available
Live Product Theater with Q&A
Anthony Heaney, MD, PhD
University of California-Los Angeles, Los Angeles, California, USA
Dr. Heaney is a Professor at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). His primary areas of clinical and research interest involve the pathogenesis of pituitary tumors and exploiting novel molecular targets to develop innovative treatments for pituitary tumors, and other neuroendocrine tumors. Dr. Heaney has published extensively.

Disclosures:

N/A - No CME credits
sponsored by:
Chiasma, Inc.
LYUMJEV™ (insulin lispro-aabc) Injection
Not Currently Available
Live Product Theater with Q&A
Thomas C. Blevins, MD
Texas Diabetes and Endocrinology, Austin, Texas, USA
Thomas C. Blevins, MD, is an endocrinologist in private practice at Texas Diabetes and Endocrinology in Austin. Dr. Blevins received his medical degree from Baylor College of Medicine in Houston, Texas, where he also completed an internship and residency in medicine and a fellowship in endocrinology and metabolism. He is board certified in lipidology and internal medicine, with a subspecialty certification in endocrinology and metabolism. Dr. Blevins is a Fellow of the American Association of Clinical Endocrinologists and the National Lipid Association. He has been involved in several diabetes-related clinical trials.
sponsored by:
Lilly Diabetes
A Paradigm Shift for the Management of Thyroid Eye Disease (TED)
Not Currently Available
Live Product Theater with Q&A
Gary J. Lelli, Jr., MD
New York-Presbyterian Hospital Weill Cornell Department of Ophthalmology, New York, New York, USA
Gary J. Lelli is Vice Chair of Ophthalmology, Director of Ophthalmic Plastic, Reconstructive, and Orbital Surgery, and Associate Professor of Ophthalmology at Weill Cornell Medical Center/New York-Presbyterian Hospital in New York, NY. Dr. Lelli completed his American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) at the combined New York City ASOPRS program, where he now serves as the fellowship director. Dr. Lelli is a member of multiple professional societies and has written numerous papers and textbook chapters. In addition to presenting at national and international meetings, Dr. Lelli actively participates in global mission work, and to this end, has taught and performed surgeries in East Africa. Dr. Lelli’s clinical interests include eyelid, orbital, and lacrimal system disorders.
sponsored by:
Horizon Therapeutics